Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 4, Number 1—March 1998


Proteases of Malaria Parasites: New Targets for Chemotherapy

Philip J. RosenthalComments to Author 
Author affiliation: San Francisco General Hospital and University of California, San Francisco, California, USA

Main Article

Table 2

New antimalarial drugs

Drug Role Best Feature(s) Limitations
Halofantrine TX of Pf malaria; not approved for CP Usually effective against R Pf malaria Variable bioavailability, cardiac toxicity
Artemisinin and related compoundsa TX of Pf malaria Rapidly acting; effective against multidrug-R strains Recurrence after TX fairly common
Atovaquone ? TX of Pf malaria; ? CP (probably in combination with proguanil) Limited toxicity Limited studies so far show frequent recurrence after TX
Pyronaridinea ? TX of Pf malaria Effective against R strains Studies limited to date
Desferrioxamine ? TX of severe Pf malaria Well tolerated when used for iron overload Studies limited to date
Azithromycin ? CP Limited toxicity Studies limited to date

For abbreviations, see Table 1, footnote a.
aNot available in the United States.

Main Article